17 April 2024 - International regulators have published a report today presenting the outcomes of a workshop on COVID-19 vaccine ...
26 March 2024 - EMA has issued recommendations for the influenza virus strains that vaccine manufacturers should include in vaccines for ...
13 March 2024 - Prevenar 20 (20 valent pneumococcal conjugate vaccine) offers the broadest serotype coverage of any paediatric pneumococcal ...
29 January 2024 - Application supported by positive results of a Phase 3 trial showing immune response and acceptable tolerability ...
1 December 2023 - The European Medicines Regulatory Network has been at the forefront of the fight against COVID-19 with ...
27 November 2023 - Valneva today announced that the EMA has performed a technical validation of the marketing authorisation application ...
31 October 2023 - The EMA’s CHMP has recommended authorising an adapted Nuvaxovid vaccine targeting the Omicron XBB.1.5 subvariant of ...
25 October 2023 - Valneva today announces the submission of a marketing application with the EMA for approval of the ...
16 October 2023 - European Union regulators have delayed a decision to give approval for Novavax's variant-tailored COVID-19 vaccine, the ...
14 September 2023 - EMA’s human medicines committee (CHMP) has recommended authorising an adapted Spikevax vaccine targeting the Omicron XBB.1.5 ...
7 September 2023 - Milestone signifies on-going effort to help prepare for outbreaks of Zaire ebolavirus. ...
5 September 2023 - EMA application supported by Phase 3 primary vaccination study demonstrating primary efficacy endpoint was met. ...
30 August 2023 - The EMA’s CHMP has recommended authorising an adapted Comirnaty vaccine targeting the Omicron XBB.1.5 subvariant. ...
24 August 2023 - Abrysvo is the first and only RSV vaccine approved in the European Union for both older ...
21 July 2023 - EMA has recommended granting a marketing authorisation in the European Union for Abrysvo, a vaccine to protect ...